Status:
COMPLETED
Making Decisions About Depression Medications
Lead Sponsor:
Victor Montori
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the Depression Medication Choice decision aid is effective in involving patients with depression in making deliberate choices when considering medicat...
Detailed Description
To determine the ability of decision aids to effectively translate a depression comparative effectiveness research (CER) review into practice, the investigators have developed a literacy-sensitive dep...
Eligibility Criteria
Inclusion
- Presumed diagnosis of depression (PHQ-9 of 10 or greater)
- As judged by clinician, need to initiate drug treatment for depression
- Identify primary care clinician as main depression provider
- Agree to be available for follow-up survey 6 months after treatment decision
Exclusion
- Has prior diagnosis of bipolar disorder
- Has major communication barrier (severe hearing/vision impairment, dementia, cannot communicate with clinician in same language)
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT01502891
Start Date
December 1 2011
End Date
October 1 2013
Last Update
December 31 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55415
2
Mayo Clinic
Rochester, Minnesota, United States, 55905
3
Entira Family Clinics (formerly known as Family Health Services Minnesota)
Saint Paul, Minnesota, United States, 55117
4
Mayo Clinic Health System - Franciscan Healthcare
La Crosse, Wisconsin, United States, 54601